Pyrimidine nucleoside diphosphate metabolic process

pathway activity — cross-omics
GO:0009138Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Pyrimidine nucleoside diphosphate metabolic process pathway is significantly associated with the protein abundance of multiple proteins, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are MX2, CMPK2, and DDX58, each associated with the pathway in up to 8 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Pyrimidine nucleoside diphosphate metabolic process activity versus MX2 in GBM (Pearson r = 0.26).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMMX2 →+0.763+0.039<.001<.00138
HNSCCMPK2 →+0.549+0.069<.001<.00137
LSCCDDX58 →+0.556+0.048<.001<.00137
LSCCIFIT3 →+0.644+0.044<.001<.00136
GBMIRF9 →+0.318+0.048.008<.00136
GBMMX1 →+0.900+0.039<.001<.00136
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0009138 vs MX2 — GBM

Per-sample scatter of Pyrimidine nucleoside diphosphate metabolic process activity vs MX2 in GBM.

Explore this scatter interactively →

Exploration